All News

As part of American Pharmacist Month, Pharmacy Times is asking experts what they believe the value of the pharmacist is.

Dr. Joanna Lewis speaks with Crystal Yu, PharmD, Senior Manager of Integrated Health at L'Oréal, about skin care and wellness, especially with the drier winter months around the corner.

Nerivio (Theranica) remote electrical neuromodulation device found to offer similar pain relief as standard care medications as an alternative for patients with chronic migraine.

The Academy of Managed Care Pharmacy kicks off AMCP Nexus 2022 with a wide variety of educational sessions and policy discussions.

Furosemide injection 80 mg/10 mL (Furoscix; scPharmaceuticals) is indicated for the at-home treatment of congestion caused by fluid overload in adult patients with New York Heart Association Class II/III chronic heart failure.

The combination of loop diuretics with other drugs that act at different pharmacologic targets has been shown to improve diuretic response in patients with heart failure.

New research finds that mental health has replaced COVID-19 as the top health concern among Americans, but deeper analysis needs to be done into whether depression and anxiety are truly becoming more widespread.

The new data came from Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled (SHARP) study.

Inhibiting the calcium release-activated calcium channel found to be an effective approach to limit allergic asthma without affecting the body’s defenses against influenza.

Jeanine Singer, senior vice president of Field Sales and Operations at McKesson, discusses being appointed to the NCPA Innovation Center Board of Directors.

Intravenous immunoglobulin was more effective than placebo, but not more effective than plasmapheresis and corticosteroids.

New research about the risks of dementia in patients with non-affective psychotic disorders could help shape new life course models for prevention.

Keeping up with the latest immunizations and being prepared for this year's flu season is essential to staying on top of your health.

Clinical studies have shown similar efficacy between emtricitabine and tenofovir alafenamide (Descovy) and emtricitabine and tenofovir disoproxil fumarate (Truvada) for individuals at risk for HIV infection.

The vaccine prevents whooping cough in infants younger than 2 months. It can be safely administered to mothers who are in their third trimester.

New research suggests that MDMA may offer promising benefits to patients with certain unmet psychological treatment needs.

Michael Barr, MD, MBA, MACP, FRCP, discusses the importance of physicians and pharmacists sharing skills to increase positive patient outcomes.

Farah Towfic, PharmD, MBA, RPh, director, CEO Operations, US Pharmacopeia, details some of the moments that led her to the pharmacy field and the important role that mentorship played in that process.

Rucaparib is the only PARP inhibitor demonstrated to have better outcomes than a docetaxel-containing control arm, according to researchers.

There is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.

QR codes are currently used in various health care settings, such as in hospitals for patient verification, but more recently for health care-related education.

Tirzepatide received Fast Track designation from the FDA after showing superiority to placebo in treating obesity in clinical trials.

The discovery of a protective antiviral protein complex could help researchers find new ways to combat hepatitis B virus.

The pharmacologic options for irritable bowel syndrome are based on the adverse effect profile, cost, and predominant symptoms.

New research suggests that acetazolamide and standard loop-diuretic therapy may decrease congestion and prevent future hospitalizations in patients with acute decompensated heart failure.

For patients facing end-of-life care, psychedelic medicines may offer a chance to feel connected with themselves and others during such a difficult time.

New research suggests that psychedelics, and specifically ketamine, can increase neuroplasticity to help a patient with an eating disorder get “unstuck,” and help treat the disorder better than psychotherapy alone.

Prior evidence regarding the safety and efficacy of the combination of apremilast and phototherapy was lacking, prompting researchers to investigate further.